Novartis Aktie
103,98
EUR
-0,16
EUR
-0,15
%
98,12
CHF
+1,32
CHF
+1,36
%
Werbung
Novartis Aktie Analyse
04.08.21 | Novartis Buy | UBS AG | |
28.07.21 | Novartis Underweight | JP Morgan Chase & Co. | |
27.07.21 | Novartis Overweight | Morgan Stanley | |
23.07.21 | Novartis Buy | UBS AG | |
22.07.21 | Novartis Hold | Deutsche Bank AG | |
22.07.21 | Novartis Neutral | Credit Suisse Group | |
22.07.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
21.07.21 | Novartis Market-Perform | Bernstein Research | |
Werbung
|
|||
21.07.21 | Novartis Market-Perform | Bernstein Research | |
21.07.21 | Novartis Underweight | JP Morgan Chase & Co. | |
21.07.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
21.07.21 | Novartis Buy | UBS AG | |
21.07.21 | Novartis Buy | Jefferies & Company Inc. | |
20.07.21 | Novartis Underweight | JP Morgan Chase & Co. | |
12.07.21 | Novartis Buy | Jefferies & Company Inc. | |
06.07.21 | Novartis Underweight | JP Morgan Chase & Co. | |
24.06.21 | Novartis Hold | Kepler Cheuvreux | |
17.06.21 | Novartis buy | Deutsche Bank AG | |
15.06.21 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
07.06.21 | Novartis Neutral | Credit Suisse Group | |
04.06.21 | Novartis Underweight | JP Morgan Chase & Co. | |
04.06.21 | Novartis buy | UBS AG | |
04.06.21 | Novartis buy | Jefferies & Company Inc. | |
21.05.21 | Novartis Underweight | JP Morgan Chase & Co. | |
19.05.21 | Novartis Underweight | JP Morgan Chase & Co. | |
19.05.21 | Novartis buy | Deutsche Bank AG | |
14.05.21 | Novartis buy | UBS AG | |
11.05.21 | Novartis buy | Deutsche Bank AG | |
10.05.21 | Novartis buy | UBS AG | |
30.04.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
30.04.21 | Novartis buy | Deutsche Bank AG | |
28.04.21 | Novartis Underweight | Barclays Capital | |
28.04.21 | Novartis Neutral | Credit Suisse Group | |
28.04.21 | Novartis buy | Deutsche Bank AG | |
28.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
27.04.21 | Novartis buy | Jefferies & Company Inc. | |
27.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
27.04.21 | Novartis Underweight | Barclays Capital | |
27.04.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
27.04.21 | Novartis buy | UBS AG | |
27.04.21 | Novartis market-perform | Bernstein Research | |
22.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
09.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
07.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
23.03.21 | Novartis Underweight | JP Morgan Chase & Co. | |
23.03.21 | Novartis buy | Jefferies & Company Inc. | |
23.03.21 | Novartis market-perform | Bernstein Research | |
23.03.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
22.03.21 | Novartis market-perform | Bernstein Research | |
10.03.21 | Novartis buy | Deutsche Bank AG |
Werbung
Werbung